{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:53:10Z","timestamp":1791233590679,"version":"4.1.0"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Hypertensive disorders of pregnancy affect approximately 9% of pregnancies in the United States and are a leading cause of maternal morbidity and mortality. For nephrologists, these conditions sit at a critical intersection: CKD is among the strongest risk factors of preeclampsia, and pregnancy itself can unmask previously unrecognized kidney disease. The physiologic demands of gestation stress renal and vascular reserve in ways that make the pregnant and immediately postpartum patient particularly vulnerable. Preeclampsia, driven by placental release of antiangiogenic factors and widespread maternal endothelial dysfunction, produces acute cardiorenal injury that does not entirely resolve with delivery. Postpartum hypertension peaks between days 3 and 6 after delivery and is under-recognized, yet this period carries the greatest risk of preventable maternal death, with cardiovascular causes accounting for more than one third of pregnancy-related deaths. Beyond the acute phase, women with hypertensive pregnancies face accelerated trajectories toward chronic hypertension, CKD, and overall cardiometabolic risks that compound with each affected pregnancy. The postpartum visit represents a critical and underutilized opportunity to identify women who warrant nephrology evaluation, initiate renoprotective therapy, and interrupt a long-term cardiorenal disease course. Nephrologists are well positioned to recognize cardiorenal sequelae of hypertensive pregnancy and ensure that the postpartum period is not a missed opportunity for intervention. This review addresses the diagnosis, pathophysiology, and management of hypertensive disorders across the full peripartum continuum, with particular attention to the role of nephrologists in recognizing kidney disease that pregnancy has brought to light and in ensuring that delivery is not treated as a clinical end point.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000001236","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:01:02Z","timestamp":1785772862000},"page":"2306-2318","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension Management in Pregnancy and Postpartum"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1980-7798","authenticated-orcid":false,"given":"Line","family":"Malha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3913-7509","authenticated-orcid":false,"given":"Phyllis","family":"August","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"1","key":"B1-20261005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/AOG.0000000000004824","article-title":"Trends in hypertensive disorders of pregnancy in the United States from 1989 to 2020","volume":"140","author":"Bruno","year":"2022","journal-title":"Obstet Gynecol."},{"issue":"11","key":"B2-20261005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jama.2023.4934","article-title":"Screening for hypertensive disorders of pregnancy: updated evidence report and systematic review for the US preventive services task force","volume":"330","author":"Henderson","year":"2023","journal-title":"JAMA."},{"issue":"1","key":"B3-20261005","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG practice bulletin no. 203: chronic hypertension in pregnancy","volume":"133","year":"2019","journal-title":"Obstet Gynecol."},{"issue":"15","key":"B4-20261005","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1161\/CIR.0000000000001000","article-title":"Call to action: maternal health and saving mothers: a policy statement from the American Heart Association","volume":"144","author":"Mehta","year":"2021","journal-title":"Circulation."},{"issue":"6","key":"B5-20261005","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol."},{"issue":"2","key":"B6-20261005","first-page":"e174","article-title":"ACOG committee opinion no. 767: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period","volume":"133","year":"2019","journal-title":"Obstet Gynecol."},{"issue":"19","key":"B7-20261005","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N Engl J Med."},{"issue":"11","key":"B8-20261005","first-page":"e114","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"152","author":"Jones","year":"2025","journal-title":"Circulation."},{"issue":"5","key":"B9-20261005","doi-asserted-by":"crossref","first-page":"482.e1","DOI":"10.1016\/j.ajog.2024.09.006","article-title":"Blood pressure control in pregnant patients with chronic hypertension and diabetes: should <130\/80 be the target?","volume":"232","author":"Harper","year":"2025","journal-title":"Am J Obstet Gynecol."},{"issue":"5","key":"B10-20261005","doi-asserted-by":"crossref","first-page":"521.e1","DOI":"10.1016\/j.ajog.2020.10.049","article-title":"Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension","volume":"224","author":"Greenberg","year":"2021","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"B11-20261005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/HYPERTENSIONAHA.119.14252","article-title":"Increased adverse pregnancy outcomes associated with stage 1 hypertension in a low-risk cohort: evidence from 47 874 cases","volume":"75","author":"Wu","year":"2020","journal-title":"Hypertension."},{"issue":"2","key":"B12-20261005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajog.2023.01.013","article-title":"The 2017 American College of Cardiology and American Heart Association blood pressure categories in the second half of pregnancy-a systematic review of their association with adverse pregnancy outcomes","volume":"229","author":"Slade","year":"2023","journal-title":"Am J Obstet Gynecol."},{"issue":"8954","key":"B13-20261005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(95)90012-8","article-title":"Role of renin-angiotensin system in blood pressure regulation in pregnancy","volume":"345","author":"August","year":"1995","journal-title":"Lancet."},{"issue":"2","key":"B14-20261005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/HYPERTENSIONAHA.118.10854","article-title":"Renin-angiotensin-aldosterone profiles in pregnant women with chronic hypertension","volume":"72","author":"Malha","year":"2018","journal-title":"Hypertension."},{"issue":"3","key":"B15-20261005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0003-4975(01)03404-X","article-title":"Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery","volume":"73","author":"Liu","year":"2002","journal-title":"Ann Thorac Surg."},{"issue":"6","key":"B16-20261005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1096\/fasebj.7.6.7682524","article-title":"Identification of increased nitric oxide biosynthesis during pregnancy in rats","volume":"7","author":"Conrad","year":"1993","journal-title":"FASEB J."},{"issue":"4","key":"B17-20261005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1172\/JCI5630","article-title":"Relaxin is a potent renal vasodilator in conscious rats","volume":"103","author":"Danielson","year":"1999","journal-title":"J Clin Invest."},{"issue":"3","key":"B18-20261005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1385\/ENDO:18:3:239","article-title":"Angiotensin-(1-7) in normal and preeclamptic pregnancy","volume":"18","author":"Merrill","year":"2002","journal-title":"Endocrine."},{"issue":"1 Pt 2","key":"B19-20261005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.31.1.356","article-title":"Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system","volume":"31","author":"Iyer","year":"1998","journal-title":"Hypertension."},{"issue":"20","key":"B20-20261005","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJM197011122832008","article-title":"Current concepts. The kidney in pregnancy","volume":"283","author":"Lindheimer","year":"1970","journal-title":"N Engl J Med."},{"key":"B21-20261005","first-page":"S90","article-title":"Edema in pregnancy","volume":"59","author":"Davison","year":"1997","journal-title":"Kidney Int Suppl."},{"issue":"3","key":"B22-20261005","doi-asserted-by":"crossref","first-page":"F496","DOI":"10.1152\/ajprenal.00194.2003","article-title":"The dynamics of glomerular filtration in the puerperium","volume":"286","author":"Hladunewich","year":"2004","journal-title":"Am J Physiol Renal Physiol."},{"issue":"2","key":"B23-20261005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/01443610062850","article-title":"Re-evaluation of plasma creatinine concentration in normal pregnancy","volume":"20","author":"Girling","year":"2000","journal-title":"J Obstet Gynaecol."},{"issue":"1","key":"B24-20261005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.1985.12","article-title":"The effect of pregnancy on kidney function in renal allograft recipients","volume":"27","author":"Davison","year":"1985","journal-title":"Kidney Int."},{"issue":"10","key":"B25-20261005","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/jcp.41.10.1089","article-title":"Urinary excretion of albumin and retinol-binding protein during normal pregnancy","volume":"41","author":"Beetham","year":"1988","journal-title":"J Clin Pathol."},{"issue":"7651","key":"B26-20261005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.39532.543947.BE","article-title":"Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review","volume":"336","author":"Cote","year":"2008","journal-title":"BMJ."},{"issue":"4","key":"B27-20261005","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0002-9378(13)90019-3","article-title":"Normal values of urinary albumin and total protein excretion during pregnancy","volume":"171","author":"Higby","year":"1994","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"B28-20261005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1471-0528.1986.tb07883.x","article-title":"Urinary albumin excretion in pregnancy","volume":"93","author":"Lopez-Espinoza","year":"1986","journal-title":"Br J Obstet Gynaecol."},{"key":"B29-20261005","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2741\/2244","article-title":"Renal function during normal pregnancy and preeclampsia","volume":"12","author":"Jeyabalan","year":"2007","journal-title":"Front Biosci"},{"issue":"19","key":"B30-20261005","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N Engl J Med."},{"key":"B31-20261005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"5","key":"B32-20261005","doi-asserted-by":"crossref","first-page":"518.e1","DOI":"10.1016\/j.ajog.2020.11.004","article-title":"Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes","volume":"224","author":"Lai","year":"2021","journal-title":"Am J Obstet Gynecol."},{"issue":"5","key":"B33-20261005","doi-asserted-by":"crossref","first-page":"538.e1","DOI":"10.1016\/j.ajog.2021.04.261","article-title":"Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study","volume":"225","author":"Lisonkova","year":"2021","journal-title":"Am J Obstet Gynecol."},{"issue":"10297","key":"B34-20261005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet."},{"issue":"3","key":"B35-20261005","doi-asserted-by":"crossref","first-page":"H661","DOI":"10.1152\/ajpheart.00202.2020","article-title":"Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia","volume":"319","author":"Qu","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"6","key":"B36-20261005","doi-asserted-by":"crossref","first-page":"e25706","DOI":"10.1161\/HYPERTENSIONAHA.126.25706","article-title":"Role of senescence in the pathophysiology of preeclampsia and future health","volume":"83","author":"Garovic","year":"2026","journal-title":"Hypertension."},{"issue":"1","key":"B37-20261005","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/s41467-025-58157-y","article-title":"Molecular subtyping of hypertensive disorders of pregnancy","volume":"16","author":"Elovitz","year":"2025","journal-title":"Nat Commun."},{"issue":"3","key":"B38-20261005","doi-asserted-by":"crossref","first-page":"e323457","DOI":"10.1161\/ATVBAHA.125.323457","article-title":"Clinical and molecular differences of hypertensive disorders during pregnancy","volume":"46","author":"Horii","year":"2026","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"2S","key":"B39-20261005","doi-asserted-by":"crossref","first-page":"S1211","DOI":"10.1016\/j.ajog.2020.10.027","article-title":"Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy","volume":"226","author":"Hauspurg","year":"2022","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"B40-20261005","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/10641950902777747","article-title":"Postpartum course of gestational hypertension and preeclampsia","volume":"29","author":"Podymow","year":"2010","journal-title":"Hypertens Pregnancy."},{"issue":"8","key":"B41-20261005","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamacardio.2024.1389","article-title":"Postpartum ambulatory blood pressure patterns following new-onset hypertensive disorders of pregnancy","volume":"9","author":"Hauspurg","year":"2024","journal-title":"JAMA Cardiol."},{"issue":"6","key":"B42-20261005","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/AOG.0b013e3181c14e3e","article-title":"Resolution of hypertension and proteinuria after preeclampsia","volume":"114","author":"Berks","year":"2009","journal-title":"Obstet Gynecol."},{"issue":"7","key":"B43-20261005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJMra2308577","article-title":"Genetics of chronic kidney disease","volume":"391","author":"Vivante","year":"2024","journal-title":"N Engl J Med."},{"issue":"10","key":"B44-20261005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41581-025-00977-8","article-title":"Kidney health outcomes of hypertensive disorders of pregnancy","volume":"21","author":"Piccoli","year":"2025","journal-title":"Nat Rev Nephrol."},{"issue":"8","key":"B45-20261005","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/ndt\/gfab225","article-title":"Pre-eclampsia is a valuable opportunity to diagnose chronic kidney disease: a multicentre study","volume":"37","author":"Cabiddu","year":"2022","journal-title":"Nephrol Dial Transplant."},{"issue":"8","key":"B46-20261005","doi-asserted-by":"crossref","first-page":"e1003255","DOI":"10.1371\/journal.pmed.1003255","article-title":"Hypertensive disorders of pregnancy and the risk of chronic kidney disease: a Swedish registry-based cohort study","volume":"17","author":"Barrett","year":"2020","journal-title":"PLoS Med."},{"key":"B47-20261005","doi-asserted-by":"crossref","first-page":"l1516","DOI":"10.1136\/bmj.l1516","article-title":"Pre-eclampsia and risk of later kidney disease: nationwide cohort study","volume":"365","author":"Kristensen","year":"2019","journal-title":"BMJ"},{"issue":"8","key":"B48-20261005","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0706790","article-title":"Preeclampsia and the risk of end-stage renal disease","volume":"359","author":"Vikse","year":"2008","journal-title":"N Engl J Med."},{"issue":"7","key":"B49-20261005","doi-asserted-by":"crossref","first-page":"e1002875","DOI":"10.1371\/journal.pmed.1002875","article-title":"Preeclampsia and risk of end stage kidney disease: a Swedish nationwide cohort study","volume":"16","author":"Khashan","year":"2019","journal-title":"PLoS Med."},{"issue":"6","key":"B50-20261005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1053\/j.ajkd.2023.04.010","article-title":"Preeclampsia and long-term kidney outcomes: an observational cohort study","volume":"82","author":"Srialluri","year":"2023","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B51-20261005","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1038\/s41598-021-92078-2","article-title":"An observational claims data analysis on the risk of maternal chronic kidney disease after preterm delivery and preeclampsia","volume":"11","author":"Goetz","year":"2021","journal-title":"Sci Rep."},{"issue":"2","key":"B52-20261005","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension."},{"issue":"7","key":"B53-20261005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11906-015-0563-z","article-title":"Secondary hypertension in pregnancy","volume":"17","author":"Malha","year":"2015","journal-title":"Curr Hypertens Rep."},{"issue":"10","key":"B54-20261005","doi-asserted-by":"crossref","first-page":"e2436478","DOI":"10.1001\/jamanetworkopen.2024.36478","article-title":"Hypertensive disorders and cardiovascular severe maternal morbidity in the US, 2015-2019","volume":"7","author":"Malham\u00e9","year":"2024","journal-title":"JAMA Netw Open."},{"issue":"11","key":"B55-20261005","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2215\/CJN.01030119","article-title":"Hypertension in a pregnant patient: how I treat","volume":"14","author":"August","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B56-20261005","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension."},{"issue":"6","key":"B57-20261005","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ajog.2025.12.039","article-title":"Postpartum management of the hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"234","author":"Tol","year":"2026","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"B58-20261005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/AOG.0000000000003014","article-title":"ACOG committee opinion no. 762 summary: prepregnancy counseling","volume":"133","year":"2019","journal-title":"Obstet Gynecol."},{"issue":"9","key":"B59-20261005","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2215\/CJN.15121219","article-title":"Updates in diagnosis and management of preeclampsia in women with CKD","volume":"15","author":"Wiles","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B60-20261005","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/HYPERTENSIONAHA.120.14875","article-title":"Preconception blood pressure and its change into early pregnancy: early risk factors for preeclampsia and gestational hypertension","volume":"76","author":"Nobles","year":"2020","journal-title":"Hypertension."},{"issue":"3","key":"B61-20261005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.kint.2025.02.021","article-title":"Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"108","author":"Piccoli","year":"2025","journal-title":"Kidney Int."},{"key":"B62-20261005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2024.08.004","article-title":"ACE inhibitor and angiotensin receptor blocker use during pregnancy: data from the ESC registry of pregnancy and cardiac disease (ROPAC)","volume":"230","author":"van der Zande","year":"2024","journal-title":"Am J Cardiol"},{"issue":"9","key":"B63-20261005","doi-asserted-by":"crossref","first-page":"102054","DOI":"10.1016\/j.jacadv.2025.102054","article-title":"Comparative effectiveness and safety of labetalol versus nifedipine for treatment of chronic hypertension during pregnancy","volume":"4","author":"Leonard","year":"2025","journal-title":"JACC Adv."},{"key":"B64-20261005","doi-asserted-by":"crossref","first-page":"d5931","DOI":"10.1136\/bmj.d5931","article-title":"Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study","volume":"343","author":"Li","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"B65-20261005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review","volume":"73","author":"Halpern","year":"2019","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"B66-20261005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/HJH.0000000000002233","article-title":"Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study","volume":"38","author":"Weber-Schoendorfer","year":"2020","journal-title":"J Hypertens."},{"issue":"5S","key":"B67-20261005","first-page":"S1","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int."},{"issue":"18","key":"B68-20261005","doi-asserted-by":"crossref","first-page":"e902","DOI":"10.1161\/CIR.0000000000000961","article-title":"Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association","volume":"143","author":"Parikh","year":"2021","journal-title":"Circulation."},{"issue":"4","key":"B69-20261005","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/AOG.0000000000003772","article-title":"Physical activity and exercise during pregnancy and the postpartum period: ACOG committee opinion, number 804","volume":"135","year":"2020","journal-title":"Obstet Gynecol."},{"issue":"21","key":"B70-20261005","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bjsports-2018-099355","article-title":"Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"52","author":"Davenport","year":"2018","journal-title":"Br J Sports Med."},{"issue":"16","key":"B71-20261005","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jacc.2018.02.033","article-title":"Hypertension across a woman's life cycle","volume":"71","author":"Wenger","year":"2018","journal-title":"J Am Coll Cardiol."},{"issue":"14","key":"B72-20261005","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jacc.2021.01.057","article-title":"Management of women with acquired cardiovascular disease from pre-conception through pregnancy and postpartum: JACC focus seminar 3\/5","volume":"77","author":"Park","year":"2021","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"B73-20261005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/hr.2017.90","article-title":"The impact of salt intake during and after pregnancy","volume":"41","author":"Asayama","year":"2018","journal-title":"Hypertens Res."},{"issue":"1","key":"B74-20261005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jn\/nxz197","article-title":"Sodium intake during pregnancy, but not other diet recommendations aimed at preventing cardiovascular disease, is positively related to risk of hypertensive disorders of pregnancy","volume":"150","author":"Arvizu","year":"2020","journal-title":"J Nutr."},{"issue":"2","key":"B75-20261005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/ANNALS-24-01590","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: a systematic review of randomized controlled trials","volume":"178","author":"Moiz","year":"2025","journal-title":"Ann Intern Med."},{"issue":"9","key":"B76-20261005","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1210\/clinem\/dgaf288","article-title":"Preexisting diabetes and pregnancy: an Endocrine Society and European Society of Endocrinology joint clinical practice guideline","volume":"110","author":"Wyckoff","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"B77-20261005","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1001\/jama.2025.20951","article-title":"Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation","volume":"334","author":"Maya","year":"2025","journal-title":"JAMA."},{"issue":"3","key":"B78-20261005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/AOG.0000000000005995","article-title":"Gestational weight gain and hypertensive disorders of pregnancy with prepregnancy and early pregnancy glucagon-like peptide-1 receptor agonist exposure","volume":"147","author":"Pondugula","year":"2026","journal-title":"Obstet Gynecol."},{"issue":"2","key":"B79-20261005","doi-asserted-by":"crossref","first-page":"e24393","DOI":"10.1161\/HYPERTENSIONAHA.124.24393","article-title":"Blood pressure 15 to 90 days after a hypertensive disorder of pregnancy and later hypertension","volume":"83","author":"Urrutia","year":"2026","journal-title":"Hypertension."},{"issue":"2","key":"B80-20261005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJMoa2307212","article-title":"Two randomized trials of low-dose calcium supplementation in pregnancy","volume":"390","author":"Dwarkanath","year":"2024","journal-title":"N Engl J Med."},{"issue":"1","key":"B81-20261005","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG committee opinion no. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol."},{"issue":"12","key":"B82-20261005","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA."},{"issue":"7","key":"B83-20261005","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med."},{"issue":"7","key":"B84-20261005","doi-asserted-by":"crossref","first-page":"e096779","DOI":"10.1136\/bmjopen-2024-096779","article-title":"Randomised controlled trial comparing low doses of aspirin in the prevention of pre-eclampsia (ASAPP): a study protocol","volume":"15","author":"Khander","year":"2025","journal-title":"BMJ Open."},{"issue":"1","key":"B85-20261005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/AOG.0000000000006100","article-title":"Comparison of 162 mg and 81 mg aspirin for prevention of preeclampsia: a randomized controlled trial","volume":"147","author":"Khander","year":"2026","journal-title":"Obstet Gynecol."},{"issue":"1","key":"B86-20261005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension."},{"issue":"1","key":"B87-20261005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/AOG.0000000000001805","article-title":"Association between sleep-disordered breathing and hypertensive disorders of pregnancy and gestational diabetes mellitus","volume":"129","author":"Facco","year":"2017","journal-title":"Obstet Gynecol."},{"issue":"1","key":"B88-20261005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12931-023-02445-y","article-title":"Treatment of obstructive sleep apnea in high risk pregnancy: a multicenter randomized controlled trial","volume":"24","author":"Tantrakul","year":"2023","journal-title":"Respir Res."},{"issue":"5","key":"B89-20261005","doi-asserted-by":"crossref","first-page":"e005526","DOI":"10.1161\/JAHA.117.005526","article-title":"Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta-analysis","volume":"6","author":"Webster","year":"2017","journal-title":"J Am Heart Assoc."},{"issue":"4","key":"B90-20261005","first-page":"CD003514","article-title":"Bed rest with or without hospitalisation for hypertension during pregnancy","volume":"2005","author":"Meher","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"B91-20261005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/AOG.0000000000005613","article-title":"Pregnancy outcomes of nifedipine compared with labetalol for oral treatment of mild chronic hypertension","volume":"144","author":"Sanusi","year":"2024","journal-title":"Obstet Gynecol."},{"issue":"4","key":"B92-20261005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajog.2025.04.011","article-title":"Oral antihypertensive treatment during pregnancy: a systematic review and network meta-analysis","volume":"233","author":"Hup","year":"2025","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"B93-20261005","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/HYPERTENSIONAHA.121.18415","article-title":"Oral antihypertensives for nonsevere pregnancy hypertension: systematic review, network meta- and trial sequential analyses","volume":"79","author":"Bone","year":"2022","journal-title":"Hypertension"},{"issue":"8","key":"B94-20261005","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1515\/jpm-2024-0114","article-title":"Does atenolol use during pregnancy cause small for gestational age neonates? A meta-analysis","volume":"52","author":"Bratton","year":"2024","journal-title":"J Perinatal Med."},{"key":"B95-20261005","doi-asserted-by":"crossref","first-page":"132234","DOI":"10.1016\/j.ijcard.2024.132234","article-title":"Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC)","volume":"410","author":"Ramlakhan","year":"2024","journal-title":"Int J Cardiol"},{"issue":"10","key":"B96-20261005","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1055\/a-2486-8840","article-title":"Daily versus twice daily nifedipine for blood pressure control in pregnancy and postpartum","volume":"42","author":"Peterson","year":"2025","journal-title":"Am J Perinatol."},{"issue":"10","key":"B97-20261005","first-page":"CD003106","article-title":"Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation","volume":"10","author":"Churchill","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"issue":"11","key":"B98-20261005","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s41440-019-0300-0","article-title":"Oral short-acting antihypertensive medications and the occurrence of stroke: a nationwide case-crossover study","volume":"42","author":"Hsu","year":"2019","journal-title":"Hypertens Res."},{"issue":"16","key":"B99-20261005","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1996.03540160050032","article-title":"Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?","volume":"276","author":"Grossman","year":"1996","journal-title":"JAMA."},{"issue":"13","key":"B100-20261005","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318230201a","article-title":"Short-acting nifedipine and risk of stroke in elderly hypertensive patients","volume":"77","author":"Jung","year":"2011","journal-title":"Neurology."},{"issue":"2","key":"B101-20261005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/HYPERTENSIONAHA.122.19275","article-title":"De novo postpartum hypertension: incidence and risk factors at a safety-net hospital","volume":"80","author":"Parker","year":"2023","journal-title":"Hypertension"},{"issue":"1","key":"B102-20261005","doi-asserted-by":"crossref","first-page":"65.e1","DOI":"10.1016\/j.ajog.2023.04.006","article-title":"Association between hypertensive disorders of pregnancy and cardiovascular diseases within 24 months after delivery","volume":"229","author":"Ackerman-Banks","year":"2023","journal-title":"Am J Obstet Gynecol."},{"issue":"7","key":"B103-20261005","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1161\/CIR.0000000000001212","article-title":"Opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes: a scientific statement from the American Heart Association","volume":"149","author":"Lewey","year":"2024","journal-title":"Circulation."},{"issue":"25","key":"B104-20261005","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1080\/14767058.2021.2012650","article-title":"Longitudinal blood pressure patterns of women with hypertensive disorders of pregnancy: preconception through postpartum","volume":"35","author":"Mukhtarova","year":"2022","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"4","key":"B105-20261005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/CRD.0b013e31821ddcf4","article-title":"The effects of nonsteroidal anti-inflammatory drugs on blood pressure in hypertensive patients","volume":"19","author":"Snowden","year":"2011","journal-title":"Cardiol Rev."},{"issue":"6","key":"B106-20261005","doi-asserted-by":"crossref","first-page":"616.e1","DOI":"10.1016\/j.ajog.2018.02.016","article-title":"Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial","volume":"218","author":"Blue","year":"2018","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"B107-20261005","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1161\/STR.0000000000000514","article-title":"Prevention and treatment of maternal stroke in pregnancy and postpartum: a scientific statement from the American Heart Association","volume":"57","author":"Miller","year":"2026","journal-title":"Stroke."},{"issue":"7","key":"B108-20261005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.123.067597","article-title":"Cardiac remodeling after hypertensive pregnancy following physician-optimized blood pressure self-management: the POP-HT randomized clinical trial imaging substudy","volume":"149","author":"Kitt","year":"2024","journal-title":"Circulation."},{"issue":"3","key":"B109-20261005","doi-asserted-by":"crossref","first-page":"101617","DOI":"10.1016\/j.jacadv.2025.101617","article-title":"Management of postpartum preeclampsia and hypertensive disorders (MOPP): postpartum tight vs standard blood pressure control","volume":"4","author":"Rosenfeld","year":"2025","journal-title":"JACC Adv."},{"issue":"6 Pt 1","key":"B110-20261005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.HYP.21.6.875","article-title":"Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension","volume":"21","author":"Ferri","year":"1993","journal-title":"Hypertension."},{"issue":"10","key":"B111-20261005","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1111\/bcp.14538","article-title":"Infant drug exposure via breast milk","volume":"88","author":"Verstegen","year":"2022","journal-title":"Br J Clin Pharmacol."},{"issue":"1","key":"B112-20261005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.AOG.0000148270.53433.66","article-title":"Postpartum preeclampsia management with furosemide: a randomized clinical trial","volume":"105","author":"Ascarelli","year":"2005","journal-title":"Obstet Gynecol."},{"issue":"2","key":"B113-20261005","doi-asserted-by":"crossref","first-page":"e24263","DOI":"10.1161\/HYPERTENSIONAHA.124.24263","article-title":"Effects of immediate postpartum diuretic treatment on postpartum blood pressure among individuals with hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"83","author":"Keen","year":"2026","journal-title":"Hypertension."},{"issue":"15","key":"B114-20261005","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2022.07.028","article-title":"Peripartum screening for postpartum hypertension in women with hypertensive disorders of pregnancy","volume":"80","author":"Giorgione","year":"2022","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"B115-20261005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/AOG.0000000000006032","article-title":"Postpartum diuretics for hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"146","author":"Trawick Roberts","year":"2025","journal-title":"Obstet Gynecol."},{"issue":"10","key":"B116-20261005","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jacc.2021.01.018","article-title":"Hypertensive disorders of pregnancy and subsequent risk of premature mortality","volume":"77","author":"Wang","year":"2021","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"B117-20261005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ppe.13055","article-title":"Pregnancy-associated mortality due to cardiovascular disease: impact of hypertensive disorders of pregnancy","volume":"38","author":"Lee","year":"2024","journal-title":"Paediatr Perinat Epidemiol."},{"issue":"3","key":"B118-20261005","doi-asserted-by":"crossref","first-page":"296.e1","DOI":"10.1016\/j.ajog.2023.03.021","article-title":"Time to onset of cardiovascular and cerebrovascular outcomes after hypertensive disorders of pregnancy: a nationwide, population-based retrospective cohort study","volume":"229","author":"Simon","year":"2023","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"B119-20261005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2019.03.033","article-title":"A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia","volume":"96","author":"Covella","year":"2019","journal-title":"Kidney Int."},{"issue":"12","key":"B120-20261005","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000475","article-title":"2024 guideline for the primary prevention of stroke: a guideline from the American Heart Association\/American Stroke Association","volume":"55","author":"Bushnell","year":"2024","journal-title":"Stroke."},{"issue":"5","key":"B121-20261005","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2022.06.038","article-title":"Preeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation","volume":"227","author":"Louis","year":"2022","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"B122-20261005","doi-asserted-by":"crossref","first-page":"e1920964","DOI":"10.1001\/jamanetworkopen.2019.20964","article-title":"Adverse pregnancy outcomes and long-term maternal kidney disease: a systematic review and meta-analysis","volume":"3","author":"Barrett","year":"2020","journal-title":"JAMA Netw Open."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:01:10Z","timestamp":1791230470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":122,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001236","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}